Location: Beverely Hills, CA
CIK: 0002039349 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $144M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP | 132,500 | $6.514M | 4.5% | $45.48 | 0.0% | COM | 80706P103 |
| SION | SIONNA THERAPEUTICS INC | 136,000 | $5.452M | 3.8% | $39.25 | 0.0% | COM | 829401108 |
| ALLO | ALLOGENE THERAPEUTICS INC | 1,430,000 | $3.489M | 2.4% | $1.74 | 0.0% | COM | 019770106 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1,257,495 (+63.4%) | $5.621M (-76.6%) | 3.9% | $20.83 | — | SPONSORED ADS | 881624209 |
| VIR | VIR BIOTECHNOLOGY INC | 1,518,552 (+63.2%) | $13.61M (+142.5%) | 9.5% | $6.44 | +11.9% | COM | 92764N102 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TSHA | TAYSHA GENE THERAPIES INC | 737,550 (-44.6%) | $22.22M (+203.5%) | 15.5% | $4.86 | -2.0% | COM SHS | 877619106 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 126,985 (-43.3%) | $4.612M (-55.8%) | 3.2% | $44.52 | +10.5% | COM | 22663K107 |
| KYTX | KYVERNA THERAPEUTICS INC | 4,244,818 (-3.3%) | $36.63M (-11.3%) | 25.5% | $7.42 | +11.8% | COM | 501976104 |
| TARS | TARSUS PHARMACEUTICALS INC | 42,680 (-36.0%) | $2.994M (-45.2%) | 2.1% | $74.67 | -6.6% | COM | 87650L103 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 289,101 (-12.2%) | $6.057M (-20.0%) | 4.2% | $32.88 | -29.0% | COM | 90400D108 |
| BLCO | BAUSCH PLUS LOMB CORP | 573,472 (-6.5%) | $9.118M (-13.0%) | 6.4% | $15.86 | +8.6% | COMMON SHARES | 071705107 |
| INCY | INCYTE CORP | 43,300 (-20.6%) | $4.075M (-24.3%) | 2.8% | $96.76 | +6.6% | COM | 45337C102 |
| AMGN | AMGEN INC | 20,212 (-12.9%) | $7.112M (-6.4%) | 5.0% | $315.95 | +10.7% | COM | 031162100 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PYXS | PYXIS ONCOLOGY INC | 4,121,870 | $6.018M | 4.2% | $3.53 | -56.6% | COMMON STOCK | 747324101 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 170,307 | $5.402M | 3.8% | $26.34 | -3.5% | COM NEW | 15117B202 |
| INSM | INSMED INC | 28,587 | $4.675M | 3.3% | $182.48 | -12.9% | COM PAR $.01 | 457669307 |